Solved

Rosh Pharmaceuticals Corp

Question 46

Multiple Choice

Rosh Pharmaceuticals Corp.is based in Israel but it maintains intellectual property protection of all its drugs with the Canadian Patent Office.What is most likely to be the result if insufficient quantities of Rosh Pharmaceuticals Corp.'s newly patented pancreatic cancer drug are produced to meet demand in Canada?


A) the loss of intellectual property rights
B) the licence will go to a Canadian facility
C) the assignment will go to a Canadian facility
D) the assignment of patent rights

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions